Company Profiles

driven by the PitchBook Platform

Achelois Pharmaceuticals

Achelois Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
2 INVESTORS
Description

Developer of non toxic therapeutics. The company develops non toxic therapeutics to inhibit tumors and eliminate pain caused by cancer.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
953 Indiana Street
San Francisco, CA 94107
United States

+1 (650) 279-7468
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Achelois Pharmaceuticals’s full profile, request a free trial.

Achelois Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Achelois Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0

Achelois Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Chang-Zheng Chen Ph.D Founder